Startup Orbis Medicines Launches With €26M for Next-Generation Peptide Drugs

Orbis Medicines, a biotech company based in Copenhagen, aims to develop peptide-based drugs that can be dosed orally, unlike traditional biologic drugs that require injection or infusion. Backed by €26 million in seed financing, Orbis’s technology platform enables the design of macrocycles with desired properties such as oral bioavailability and cellular permeability. These compounds have…

Read More

“I Am Number 17” campaign opens at St Stephen’s Green, bringing visibility to Ireland’s rare disease community

The ‘I Am Number 17’ campaign in Ireland aims to bring awareness to rare diseases, with statistics showing that 1 in 17 people will be affected by one in their lifetime. An exhibition featuring 17 individuals living with rare diseases has been launched in Dublin, showcasing their resilience and stories. The campaign, funded by Takeda…

Read More

Videocapsule Endoscopy Boosts Diagnostic Accuracy in Nonovert Bleeding IDA

Videocapsule endoscopy (VCE) is seen as a valuable tool in diagnosing nonovert bleeding patients with iron deficiency anemia (IDA) with high accuracy. IDA, a common cause of anemia globally, often leads to referrals to gastroenterologists for gastrointestinal issues. Despite standard examinations, many IDA patients go undiagnosed, prompting the use of VCE for a thorough examination…

Read More

Data exchange company Moxe Health secures $25M

Moxe Health, a healthcare data exchange startup, raised $25 million in growth capital from Trinity Capital. The company provides tools for sharing patient health record information, including a convergence product for payers and a digital release of information product for providers. The investment will be used to scale operations. The healthcare data exchange market is…

Read More

Alabama’s IVF Ruling Still Making Waves

Julie Rovner, the chief Washington correspondent and host of KFF Health News’ podcast “What the Health?” discussed the Alabama Supreme Court’s ruling that embryos are legally children. Lawmakers in Alabama and Florida are dealing with the impact of this ruling on in vitro fertilization. Congress is close to a funding deal for the fiscal year,…

Read More

VA’s HCV elimination program ‘incredibly successful’

A study on veterans with hepatitis C found that an overall successful hepatitis C elimination program by the Department of Veterans Affairs resulted in 80.1% of veterans initiating treatment, with 91.6% achieving sustained virologic response. Younger veterans were less likely to initiate treatment and achieve SVR. Factors such as stimulant and opioid use, unstable housing,…

Read More

Raising the bar for disclosure of industry payments to doctors

Menkes and colleagues argue that transparent reporting of drug industry payments to doctors is crucial to managing conflicts of interest. In 2022, New Zealand saw its first disclosures of financial relationships between drug companies and health professionals. While this was a step towards transparency, it was limited, with some payment types omitted. International comparisons show…

Read More